You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (20)

Journals (0)

1-10 of 20 results for Biosimilar bevacizumab

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Off-label infusion of biosimilar bevacizumab: A provincial experience

Retricted access

Research article

First published 2020-10

Off-label infusion of biosimilar bevacizumab: A provincial experience

Marc Geirnaert, Jacy Howarth, Curtis Kellett [...]

Journal of Oncology Pharmacy Practice

Select article: Efficacy and Safety of Bevacizumab Biosimilar (Encoda) Compared With Reference Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer: A Multicenter,Real-World Study

Open access

Research article

First published 2024

Efficacy and Safety of Bevacizumab Biosimilar (Encoda) Compared With Reference Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer: A Multicenter,Real-World Study

Han Shan, Mengmeng Wang, Shuohan Huang [...]

Clinical Medicine Insights: Oncology

Select article: Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

Open access

Research article

First published 2023

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

Ran Jin, Adesuwa S. Ogbomo, Neil A. Accortt [...]

Therapeutic Advances in Medical Oncology

Select article: Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US

Open access

Research article

First published 2021

Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US

Ran Jin, Reshma L. Mahtani, Neil Accortt [...]

Therapeutic Advances in Medical Oncology

Select article: Physicochemical stability of PF-06439535 (bevacizumab-bvzr;Zirabev ® ),a bevacizumab biosimilar,under extended in-use conditions

Open access

Research article

First published 2023-7

Physicochemical stability of PF-06439535 (bevacizumab-bvzr;Zirabev ® ),a bevacizumab biosimilar,under extended in-use conditions

Sarah Weiser, Chris Burns, Edward R. Zartler

Journal of Oncology Pharmacy Practice

Select article: Efficacy and safety of adding bevacizumab biosimilar or original drug to platinum-based chemotherapy as first-line treatment in patients with advanced NSCLC: a systematic review and meta-analysis

Open access

Research article

First published 2022

Efficacy and safety of adding bevacizumab biosimilar or original drug to platinum-based chemotherapy as first-line treatment in patients with advanced NSCLC: a systematic review and meta-analysis

Liu Yang, Maobai Liu, Xueqiong Cao [...]

Therapeutic Advances in Medical Oncology

Select article: Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer

Open access

Research article

First published 2024

Real-world clinical efficacy of bevacizumab biosimilar in patients with advanced non-small-cell lung cancer

Wei-Fan Ou, Kuo-Hsuan Hsu, Jeng-Sen Tseng [...]

Therapeutic Advances in Medical Oncology

Select article: Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer

Open access

Research article

First published 2021

Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer

Mark A. Socinski, Cornelius F. Waller, Tazeen Idris [...]

Therapeutic Advances in Medical Oncology

Select article: Retrospective Indication-Matched Cohort Study of Reference Product and Biosimilar: Bevacizumab Versus Bevacizumab-Awwb

Retricted access

Research article

First published 2022-8

Retrospective Indication-Matched Cohort Study of Reference Product and Biosimilar: Bevacizumab Versus Bevacizumab-Awwb

Jennifer Philippon Booth, Jeffrey Pilz

Hospital Pharmacy

Select article: Ocular Safety and Toxicokinetics of Bevacizumab-bvzr (Zirabev),a Bevacizumab Biosimilar,Administered to Cynomolgus Monkeys by Intravitreal Injection

Open access

Research article

First published 2023-04

Ocular Safety and Toxicokinetics of Bevacizumab-bvzr (Zirabev),a Bevacizumab Biosimilar,Administered to Cynomolgus Monkeys by Intravitreal Injection

Marjorie A. Peraza, Susan Hurst, Wenhu Huang [...]

Journal of Ocular Pharmacology and Therapeutics

1
2
10 / page

Article type

Publication date

Subjects

Access